Abstract
Immunocompromised patients who have SARS-CoV-2 infection pose many clinical and public health challenges. We describe a patient with hematopoietic stem cell transplantation and lymphoma with protracted illness requiring 3 consecutive hospital admissions. Whole genome sequencing confirmed two different SARS-CoV-2 clades. Clinical management issues, and unanswered questions arising are discussed.
Original language | English (US) |
---|---|
Journal | International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases |
DOIs | |
State | Published - Jul 21 2021 |
Bibliographical note
KAUST Repository Item: Exported on 2021-07-27Acknowledgements: Sir Zumla is co-Principal Investigator of the Pan African-European Network on Emerging and Re-Emerging Infections (PANDORA-ID-NET–https://www.pandora-id.net/) funded by the European and Developing Countries Clinical Trials Partnership the EU Horizon 2020 Framework Programme. Sir Zumla is in receipt of a UK National Institutes of Health Research senior investigator award and is a 2020 Mahathir Science Award Laurette.
The authors acknowledge the generous charitable donation from the late Sheikh Ibraheem Ahmed Azhar in the form of reagents and supplies as a contribution to the scientific research community.
ASJC Scopus subject areas
- Infectious Diseases
- Microbiology (medical)